OBJECTIVE	The results of the Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction ( S-ACCESS ) , a randomized double-blind study of sarpogrelate ( selective 5-HT ( 2A ) receptor antagonist ) versus aspirin in 1510 Japanese patients , have been reported .\